You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
恒指随美股期货涨逾百点 石药/复星医药/药明/歌礼制药涨4%-12%
阿思达克 11-07 15:44

医药板块今天普遍跑赢大市,先後获高盛及光大证券重申「买入」分别升价至25.8元及维持看23.1元的石药集团(01093.HK)再探顶,最高见21.6元,创逾15个月高,现造21.5元,续升4.9%,为最强蓝筹,成交增至4,277万股。

复星医药(02196.HK)高见24.3元,暂受制牛熊线(24.4元),现造23.65元,回升4.6%。联邦制药(03933.HK)升约4%报4.8元,创两个月高;蓝筹中生制药(01177.HK)续升2.2%报12.1元。

上周趁高以折让逾8%每股8.5元「抽水」的药明生物(02269.HK)由逾16个月高位回落,今早考验20天线(84.4元),低见84.2元获承接,掉头重越10天线(87.1元),报88.3元,弹4.1%。

歌礼制药-B(01672.HK)回落至10及50天线附近获承接,今天买盘重现,股价高见4.04元,创逾两个月高,现造3.94元,涨12%,成交急增至1,224万股,为一年罕见。

据内地媒体引述商务部发言人高峰指中美同意随协议进展分阶段取消加徵关税。美股期货於本港时间3点过後由之前牛皮偏软,全面抽升0.4%-0.5%,道指期货最高见27,598纪录高,现造27,560,回升130点或0.5%。港股也由今早最低位27,534,抽升至27,900,创逾三个月高,现造27,804,续升115点或0.4%,成交额664亿元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account